Corpus Intelligence IC Memo — KELL WEST REGIONAL HOSPITAL 2026-04-26 11:19 UTC
IC Memo — KELL WEST REGIONAL HOSPITAL
Investment Committee Memorandum | TX | 41 beds | Grade D | EBITDA uplift $2.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KELL WEST REGIONAL HOSPITAL

CCN 450827 | WICHITA, TX | 41 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

KELL WEST REGIONAL HOSPITAL is a 41-bed rural/critical access in WICHITA, TX with $34.5M in net patient revenue and a -3.9% operating margin. The hospital serves a payer mix of 46.6% Medicare, 2.0% Medicaid, and 51.3% commercial.

Thesis: Turnaround. Our ML models identify $2.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.9% to 3.5% (+736bps).

Net Revenue HCRIS$34.5M
Current EBITDA COMPUTED$-1.4M
Operating Margin COMPUTED-3.9%
Occupancy HCRIS11.5%
Revenue / Bed COMPUTED$842K
Net-to-Gross HCRIS36.3%
Distress Probability ML58.3%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
278
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -3.9% places it below the state median. Among 278 size-comparable peers (20-82 beds), the median margin is -2.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-82), prioritizing same-state peers. 278 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KELL WEST REGIONAL HOSPITAL (Target)TX41$34.5M-3.9%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$725K+210bp18mo
Cost to Collect4.5%2.5%$691K+200bp12mo
Denial Rate Reduction12.0%6.5%$684K+198bp12mo
A/R Days Reduction5200.0%3800.0%$420K+122bp9mo
Clean Claim Rate88.0%96.0%$22K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$725K
Cost to Collect
$691K
Denial Rate Reduction
$684K
A/R Days Reduction
$420K
Clean Claim Rate
$22K
Total EBITDA Uplift$2.5M
Current EBITDA$-1.4M
+ RCM Uplift+$2.5M
Pro Forma EBITDA$1.2M
Current Margin-3.9%
Pro Forma Margin3.5%
WC Released (1x)$1.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.1M$16.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.1M$17.5M0.00x-100.0%
Bull Case9.0x11.0x$-1.9M$25.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.9M$26.9M0.00x-100.0%
Bear Case11.0x10.0x$-2.3M$4.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.3M$4.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 11.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 58.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 278 hospitals with 20-82 beds
  • Same-state prioritization (n=279)
  • Comp margins: P25=-23.0% / P50=-2.4% / P75=10.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.